(ENTG) Entegris - NASDAQ
Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: NASDAQ (USA) | Market Cap: 22.924m USD | Total Return: 106.3% in 12m
Avg Turnover: 421M
EPS Trend: 29.8%
Qual. Beats: 2
Rev. Trend: -84.2%
Qual. Beats: 0
Warnings
P/E ratio 87.0
Tailwinds
Confidence
Entegris, Inc. is a global provider of advanced materials and process solutions primarily serving the semiconductor industry. The company operates through two main segments: Materials Solutions (MS), which focuses on deposition and etch chemistries, and Advanced Purity Solutions (APS), which provides critical filtration and contamination control systems. Its customer base spans logic and memory manufacturers, equipment makers, and specialized industrial sectors including life sciences and aerospace.
The semiconductor materials sector is characterized by high barriers to entry due to the extreme purity requirements and complex chemical engineering necessary for sub-10nm chip fabrication. As a key supplier to the wafer fab ecosystem, Entegris utilizes a recurring revenue model where consumables like slurries and filters are continuously replaced during the manufacturing process. You can evaluate the company’s valuation metrics and historical performance trends on ValueRay.
Founded in 1966 and headquartered in Billerica, Massachusetts, Entegris maintains a significant international footprint with operations across North America, Asia, and Europe. The firm’s integration into the global supply chain makes it a critical partner for both leading-edge logic production and mature node semiconductor manufacturing.
- Transition to sub-2nm nodes increases demand for advanced filtration and high-purity materials
- Global semiconductor capital expenditure cycles dictate volume for wafer handling and purification systems
- Expansion of high-performance computing and AI chips drives specialty chemical revenue growth
- Geopolitical trade restrictions on advanced logic manufacturing impact sales to the Chinese market
| Net Income: 264.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.84 > 1.0 |
| NWC/Revenue: 38.03% < 20% (prev 35.69%; Δ 2.34% < -1%) |
| CFO/TA 0.09 > 3% & CFO 738.0m > Net Income 264.5m |
| Net Debt (3.42b) to EBITDA (845.8m): 4.04 < 3 |
| Current Ratio: 3.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (153.2m) vs 12m ago 0.79% < -2% |
| Gross Margin: 43.22% > 18% (prev 44.56%; Δ -1.34% > 0.5%) |
| Asset Turnover: 38.27% > 50% (prev 38.47%; Δ -0.20% > 0%) |
| Interest Coverage Ratio: 2.44 > 6 (EBIT TTM 472.1m / Interest Expense TTM 193.4m) |
| A: 0.15 (Total Current Assets 1.79b - Total Current Liabilities 555.6m) / Total Assets 8.48b |
| B: 0.19 (Retained Earnings 1.64b / Total Assets 8.48b) |
| C: 0.06 (EBIT TTM 472.1m / Avg Total Assets 8.45b) |
| D: 0.91 (Book Value of Equity 4.05b / Total Liabilities 4.43b) |
| Altman-Z'' = 2.92 = A |
| DSRI: 0.99 (Receivables 529.5m/538.5m, Revenue 3.24b/3.24b) |
| GMI: 1.03 (GM 44.56% / 43.22%) |
| AQI: 0.98 (AQ_t 0.58 / AQ_t-1 0.60) |
| SGI: 1.00 (Revenue 3.24b / 3.24b) |
| TATA: -0.06 (NI 264.5m - CFO 738.0m) / TA 8.48b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of June 18, 2026, the stock is trading at USD 157.34 with a total of 2,492,767 shares traded.
Over the past week, the price has changed by +22.08%,
over one month by +23.69%,
over three months by +35.64% and
over the past year by +106.30%.
Entegris has received a consensus analysts rating of 4.44. Therefore, it is recommended to buy ENTG.
- StrongBuy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 160.6 | 2.1% |
P/E Trailing = 87.0058
P/E Forward = 43.29
P/S = 7.0856
P/B = 5.6614
P/EG = 1.8432
Revenue TTM = 3.24b USD
EBIT TTM = 472.1m USD
EBITDA TTM = 845.8m USD
Long Term Debt = 3.65b USD (from longTermDebt, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 106.3m
Net Debt = 3.42b USD (calculated: Debt 3.86b - CCE 442.7m)
Enterprise Value = 26.3b USD (22.9b + Debt 3.86b - CCE 442.7m)
Interest Coverage Ratio = 2.44 (Ebit TTM 472.1m / Interest Expense TTM 193.4m)
EV/FCF = 38.75x (Enterprise Value 26.3b / FCF TTM 679.8m)
FCF Yield = 2.58% (FCF TTM 679.8m / Enterprise Value 26.3b)
FCF Margin = 21.01% (FCF TTM 679.8m / Revenue TTM 3.24b)
Net Margin = 8.18% (Net Income TTM 264.5m / Revenue TTM 3.24b)
Gross Margin = 43.22% ((Revenue TTM 3.24b - Cost of Revenue TTM 1.84b) / Revenue TTM)
Gross Margin QoQ = 41.24% (prev 43.77%)
Tobins Q-Ratio = 3.11 (Enterprise Value 26.3b / Total Assets 8.48b)
Interest Expense / Debt = 5.01% (Interest Expense 193.4m / Debt 3.86b)
Taxrate = 3.92% (10.8m / 275.8m)
NOPAT = 453.6m (EBIT 472.1m * (1 - 3.92%))
Current Ratio = 3.21 (Total Current Assets 1.79b / Total Current Liabilities 555.6m)
Debt / Equity = 0.95 (Debt 3.86b / totalStockholderEquity, last quarter 4.05b)
Debt / EBITDA = 4.04 (Net Debt 3.42b / EBITDA 845.8m)
Debt / FCF = 5.03 (Net Debt 3.42b / FCF TTM 679.8m)
Total Stockholder Equity = 3.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 264.5m / Total Assets 8.48b)
RoE = 6.74% (Net Income TTM 264.5m / Total Stockholder Equity 3.93b)
RoCE = 6.23% (EBIT 472.1m / Capital Employed (Equity 3.93b + L.T.Debt 3.65b))
RoIC = 5.84% (NOPAT 453.6m / Invested Capital 7.77b)
WACC = 12.92% (E(22.9b)/V(26.8b) * Re(14.29%) + D(3.86b)/V(26.8b) * Rd(5.01%) * (1-Tc(0.04)))
Discount Rate = 14.29% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 94.39 | Cagr: 0.55%
[DCF] Terminal Value 64.65% ; FCFF base≈515.1m ; Y1≈590.4m ; Y5≈869.0m
[DCF] Fair Price = 24.81 (EV 7.20b - Net Debt 3.42b = Equity 3.78b / Shares 152.3m; r=12.92% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 29.85 | EPS CAGR: 3.24% | SUE: 4.0 | # QB: 2
Revenue Correlation: -84.23 | Revenue CAGR: -5.11% | SUE: 0.33 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.82 | Chg30d=+5.42% | Revisions=+69% | Analysts=10
EPS next Quarter (2026-09-30): EPS=0.92 | Chg30d=+2.02% | Revisions=+17% | Analysts=10
EPS current Year (2026-12-31): EPS=3.64 | Chg30d=+6.66% | Revisions=+71% | GrowthEPS=+32.3% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=4.62 | Chg30d=+4.36% | Revisions=+47% | GrowthEPS=+27.0% | GrowthRev=+11.5%
[Analyst] Revisions Ratio: +71%